Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...
The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...
MyoRegulator, a neuromodulation device, has been granted FDA breakthrough status for the treatment of ALS. The noninvasive device delivers gentle electrical currents to nerves and the spinal cord to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback